Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Myasthenia associated with D-penicillamine therapy in rheumatoid arthritis.

Literature DB >> 122656

Myasthenia associated with D-penicillamine therapy in rheumatoid arthritis.

R C Bucknall¹.

Abstract

Entities: Chemical Disease

Mesh：

Substances：
Penicillamine

Year: 1977 PMID： 122656 PMCID： PMC1543589

Source DB: PubMed Journal: Proc R Soc Med ISSN： 0035-9157

× No keyword cloud information.

9 in total

1. Myasthenia syndrome during penicillamine treatment.

Authors: A Czlonkowska
Journal: Br Med J Date: 1975-06-28

Review 2. SJOEGREN'S SYNDROME. A CLINICAL, PATHOLOGICAL, AND SEROLOGICAL STUDY OF SIXTY-TWO CASES.

Authors: K J BLOCH; W W BUCHANAN; M J WOHL; J J BUNIM
Journal: Medicine (Baltimore) Date: 1965-05 Impact factor: 1.889

3. Letter: Penicillamine therapy, antistriational antibody, and myasthenia gravis.

Authors: R L Dawkins; P J Zilko; E T Owen
Journal: Br Med J Date: 1975-12-27

4. Letter: Immune response genes in myasthenia gravis.

Authors: P O Behan; J A Simpson; H Dick
Journal: Lancet Date: 1973-11-03 Impact factor: 79.321

5. Penicillamine nephropathy in rheumatoid arthritis. A clinical, pathological and immunological study.

Authors: P A Bacon; C R Tribe; J C Mackenzie; J Verrier-Jones; R H Cumming; B Amer
Journal: Q J Med Date: 1976-10

6. [Letter: Myasthenia and autoimmune thyroiditis during rheumatoid polyarthritis treated by D-penicillamine].

Authors: F Delrieu; C J Menkes; A Sainte-Croix; F Delbarre; P Babinet; A M Chesneau
Journal: Nouv Presse Med Date: 1975-11-22

7. Myasthenia gravis associated with penicillamine treatment for rheumatoid arthritis.

Authors: R C Bucknall; J Dixon A St; E N Glick; J Woodland; D W Zutshi
Journal: Br Med J Date: 1975-03-15

8. Experimental autoimmune myasthenia gravis and myasthenia gravis: biochemical and immunochemical aspects.

Authors: J M Lindstrom; V A Lennon; M E Seybold; S Whittingham
Journal: Ann N Y Acad Sci Date: 1976 Impact factor: 5.691

9. Myasthenia gravis, autoantibodies, and HL-A antigens.

Authors: T E Feltkamp; P M van den Berg-Loonen; L E Nijenhuis; C P Engelfriet; A L van Rossum; J J van Loghem; H J Oosterhuis
Journal: Br Med J Date: 1974-01-26

9 in total

8 in total

Myasthenia associated with D-penicillamine therapy in rheumatoid arthritis.

1. Myasthenia syndrome during penicillamine treatment.

Review 2. SJOEGREN'S SYNDROME. A CLINICAL, PATHOLOGICAL, AND SEROLOGICAL STUDY OF SIXTY-TWO CASES.

3. Letter: Penicillamine therapy, antistriational antibody, and myasthenia gravis.

4. Letter: Immune response genes in myasthenia gravis.

5. Penicillamine nephropathy in rheumatoid arthritis. A clinical, pathological and immunological study.

6. [Letter: Myasthenia and autoimmune thyroiditis during rheumatoid polyarthritis treated by D-penicillamine].

7. Myasthenia gravis associated with penicillamine treatment for rheumatoid arthritis.

8. Experimental autoimmune myasthenia gravis and myasthenia gravis: biochemical and immunochemical aspects.

9. Myasthenia gravis, autoantibodies, and HL-A antigens.

Review 1. The main immunogenic region (MIR) of the nicotinic acetylcholine receptor and the anti-MIR antibodies.

2. Fine antigenic specificities of antibodies in sera from patients with D-penicillamine-induced myasthenia gravis.

Review 3. Tissue-specific antibodies in myasthenia gravis.

4. A study of triplets with Hashimoto's thyroiditis.

5. D-penicillamine induced myasthenia gravis in rheumatoid arthritis: an unpredictable common occurrence?

6. Penicillamine-induced myasthenia in rheumatoid arthritis: its clinical and genetic features.

Review 7. A risk-benefit assessment of slow-acting antirheumatic drugs in rheumatoid arthritis.

Review 8. Therapeutic applications of botulinum neurotoxins in head and neck disorders.